📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS (2020)

First Author: Pratt A

Attributed to: MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2020-eular.2443

Publication URI: http://dx.doi.org/10.1136/annrheumdis-2020-eular.2443

Type: Journal Article/Review

Parent Publication: Annals of the Rheumatic Diseases

ISSN: 0003-4967